Eikon Therapeutics, Inc.
Biotechnology company · Millbrae, California, United States · Nasdaq: EIKN
Eikon Therapeutics, Inc. is a biotechnology company headquartered in Millbrae, California, United States. Its earliest recorded incorporation is in 2019. Its shares trade on Nasdaq under the ticker EIKN. It has reported private securities offerings to the US SEC, most recently $351 million sold in a notice filed in 2025.
Eikon Therapeutics at a glance
What does Eikon Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $350.7 million sold (2025).
Frequently asked questions about Eikon Therapeutics
Where is Eikon Therapeutics headquartered?
Eikon Therapeutics, Inc. is headquartered in Millbrae, California, United States.
What does Eikon Therapeutics do?
Eikon Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Eikon Therapeutics a public company?
Yes. Eikon Therapeutics, Inc. trades on Nasdaq under the ticker EIKN.
When was Eikon Therapeutics founded?
The earliest incorporation on record for Eikon Therapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.